Literature DB >> 7389684

Tissue organ distribution and behavioral effects of platinum following acute and repeated exposure of the mouse to platinum sulfate.

B A Lown, J B Morganti, C H Stineman, R B D'Agostino, E J Massaro.   

Abstract

Platinum sulfate was administered intragastrically (IG) to adult male Swiss mice in a single dose at the 7 day LD5 or LD25 level. Control groups received 0.25M H2SO4 (pH 0.85) or 0.14M NaCl. Open field behavior (ambulations, rearings) was measured, and tissue/organ Pt levels determined at 4 hr, or 1, 3, or 7 days post administration. At all times, the LD25 depressed ambulations significantly and rearings marginally. It did not effect exploratory ("hole-in-board") behavior. The LD25 resulted in disproportionately high tissue Pt levels relateive to the LD5. There were significant inverse correlations between behavior and tissue Pt levels for most tissues, but not for brain. In related experiments, adult male mice were subjected to repeated IG administration of Pt(SO4)2 at the LD1 level (one dose every 72 hr for up to 10 doses). Three days after administration of the final dose of each series, open-field and exploratory performance were measured and tissue/organ Pt levels determined. Tissue/organ Pt levels were variable but generally increased with dose number. No Pt was detected in the brain. Activity and explorations were marginally depressed. Only rearings correlated significantly with tissue Pt levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389684      PMCID: PMC1568532          DOI: 10.1289/ehp.8034203

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  17 in total

1.  Biological fate of a single administration of 191Pt in rats following different routes of exposure.

Authors:  W Moore; D Hysell; W Crocker; J Stara
Journal:  Environ Res       Date:  1975-04       Impact factor: 6.498

2.  Cis-diamminedichloroplatinum (NSC-119875): a phase I study.

Authors:  D J Higby; H J Wallace; J F Holland
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

Review 3.  Platinum sensitivity.

Authors:  G M Levene
Journal:  Br J Dermatol       Date:  1971-12       Impact factor: 9.302

4.  cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.

Authors:  U Schaeppi; I A Heyman; R W Fleischman; H Rosenkrantz; V Ilievski; R Phelan; D A Cooney; R D Davis
Journal:  Toxicol Appl Pharmacol       Date:  1973-06       Impact factor: 4.219

5.  Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).

Authors:  R C DeConti; B R Toftness; R C Lange; W A Creasey
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

6.  The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.

Authors:  R C Lange; R P Spencer; H C Harder
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

7.  Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.

Authors:  R W Talley; R M O'Bryan; J U Gutterman; R W Brownlee; K B McCredie
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

8.  Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).

Authors:  A H Rossof; R E Slayton; C P Perlia
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

9.  A study of the interaction of the hypnotic effects and of the toxic effects of chloral hydrate and ethanol.

Authors:  P K Gessner; B E Cabana
Journal:  J Pharmacol Exp Ther       Date:  1970-08       Impact factor: 4.030

10.  Noble metals: a toxicological appraisal of potential new environmental contaminants.

Authors:  P E Brubaker; J P Moran; K Bridbord; F G Hueter
Journal:  Environ Health Perspect       Date:  1975-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.